Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VNN1 | O95497 | 1/20 | 0.43 |
| ▸ | DPP4 | P27487 | 10/20 | 0.43 |
| ▸ | HTR1A | P08908 | 4/20 | 0.42 |
| ▸ | HTR7 | P34969 | 4/20 | 0.42 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | DHFR | P00374 | 1/20 | 0.40 |
| ▸ | ACE | P12821 | 1/20 | 0.39 |
| ▸ | MTOR | P42345 | 1/20 | 0.38 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13570397 | 0.84 | DPP4 (0.49) | VNN1DPP4HTR1AHTR7ACE | |
| SCHEMBL30874840 | 0.84 | DPP4 (0.49) | VNN1DPP4HTR1AHTR7ACE | |
| SCHEMBL30874862 | 0.82 | CYP19A1 (0.47) | VNN1DPP4HTR1AHTR7DPP9 | |
| SCHEMBL30874909 | 0.81 | VNN1 (0.47) | VNN1DPP4HTR1AHTR7DPP9 | |
| SCHEMBL16635512 | 0.80 | POLB (0.46) | VNN1 | |
| SCHEMBL30341550 | 0.78 | DPP4 (0.46) | VNN1DPP4HTR1AHTR7DPP9 | |
| SCHEMBL30874864 | 0.76 | VNN1 (0.47) | VNN1DPP4HTR1AHTR7DPP9 | |
| SCHEMBL30874914 | 0.75 | DPP4 (0.44) | DPP4HTR1AHTR7DPP9 | |
| SCHEMBL30874798 | 0.75 | VNN1 (0.62) | VNN1DPP4ACE | |
| SCHEMBL30874935 | 0.73 | DPP4 (0.41) | VNN1DPP4HTR1AHTR7DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117956985-A | Inhibitors of glycogen synthase 1 (GYS 1) and methods of use thereof | 梅兹治疗公司 | 2024-04-30 | — | — | CN | disclosed |